NASDAQ : BEAM
Beam Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 27.23 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.72B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Beam Therapeutics Inc. (BEAM) reported revenue of 156.03M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 156.03M | 139.74M | 63.52M | 377.71M | 60.92M | 51.84M |
| Cost of Revenue | 408.66M | 409.62M | 367.56M | 437.38M | 311.59M | 232.13M |
| Gross Profit | -252.63M | -269.88M | -304.04M | -59.67M | -250.67M | -180.29M |
| Selling, General & Admin | 125.39M | 113.82M | 111.53M | 116.81M | 87.81M | 57.22M |
| Operating Expenses | 125.39M | 113.82M | 111.53M | 116.81M | 87.81M | 57.22M |
| Operating Income | -378.02M | -383.69M | -415.57M | -176.49M | -338.48M | -237.51M |
| Interest Expense | -9.00K | |||||
| Interest & Investment Income | 38.90M | 43.73M | 49.09M | 46.68M | 15.30M | |
| Earnings From Equity Investments | 255.15M | 255.15M | -25.50M | |||
| Other Non Operating Income (Expenses) | -5.50M | 700.00K | 2.27M | 7.50M | 23.90M | -1.00M |
| EBT Excluding Unusual Items | -89.48M | -84.11M | -364.20M | -122.31M | -324.78M | -238.52M |
| Gain (Loss) on Sale of Investments | 2.42M | 3.94M | -14.09M | -18.59M | 20.20M | 17.69M |
| Other Unusual Items | 544.00K | 180.00K | 1.59M | 9.74M | 18.90M | 5.15M |
| Pretax Income | -86.52M | -79.99M | -376.70M | -131.16M | -285.68M | -370.64M |
| Income Tax Expense | 39.00K | 1.37M | 3.41M | |||
| Earnings From Continuing Operations | -86.52M | -79.99M | -376.74M | -132.53M | -289.09M | -370.64M |
| Net Income | -86.52M | -79.99M | -376.74M | -132.53M | -289.09M | -370.64M |
| Net Income to Common | -86.52M | -79.99M | -376.74M | -132.53M | -289.09M | -370.64M |
| Shares Outstanding (Basic) | 103.29M | 98.91M | 82.31M | 77.15M | 70.02M | 64.23M |
| Shares Outstanding (Diluted) | 103.29M | 98.91M | 82.31M | 77.15M | 70.02M | 64.23M |
| EPS (Basic) | -0.84 | -0.81 | -4.58 | -1.72 | -4.13 | -5.77 |
| EPS (Diluted) | -0.84 | -0.81 | -4.58 | -1.72 | -4.13 | -5.77 |
| Free Cash Flow | -372.77M | -360.05M | -356.19M | -182.93M | -26.42M | -113.08M |
| Free Cash Flow Per Share | -3.61 | -3.64 | -4.33 | -2.37 | -0.38 | -1.76 |
| Gross Margin | -161.91% | -193.12% | -15.80% | |||
| Operating Margin | -242.27% | -274.57% | -654.25% | -46.73% | -555.61% | -458.13% |
| Profit Margin | -55.45% | -57.24% | -593.13% | -35.09% | -474.54% | -714.91% |
| Free Cash Flow Margin | -238.90% | -257.65% | -560.77% | -48.43% | -43.38% | -218.11% |
| EBITDA | -355.78M | -361.40M | -393.64M | -156.47M | -324.33M | -230.06M |
| EBITDA Margin | -228.01% | -258.62% | -41.43% | |||
| D&A For EBITDA | 22.24M | 22.29M | 21.93M | 20.01M | 14.15M | 7.45M |
| EBIT | -378.02M | -383.69M | -415.57M | -176.49M | -338.48M | -237.51M |
| EBIT Margin | -242.27% | -274.57% | -46.73% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 219.82M | 294.94M | 281.97M | 435.89M | 232.77M | 559.99M |
| Short-Term Investments | 933.10M | 950.27M | 568.77M | 753.98M | 845.37M | 405.65M |
| Cash & Short-Term Investments | 1.15B | 1.25B | 850.74M | 1.19B | 1.08B | 965.65M |
| Receivables | 300.00M | |||||
| Prepaid Expenses | 25.67M | 23.48M | 27.41M | 21.17M | 14.76M | 7.36M |
| Total Current Assets | 1.18B | 1.27B | 878.15M | 1.21B | 1.09B | 1.27B |
| Property, Plant & Equipment | 193.19M | 205.18M | 216.28M | 237.81M | 234.13M | 186.98M |
| Other Long-Term Assets | 14.57M | 7.31M | 9.40M | 10.87M | 14.69M | 14.47M |
| Total Assets | 1.39B | 1.48B | 1.10B | 1.46B | 1.34B | 1.47B |
| Accounts Payable | 13.10M | 10.23M | 3.87M | 1.62M | 9.03M | 7.47M |
| Accrued Expenses | 27.88M | 49.64M | 36.13M | 35.05M | 30.72M | 56.87M |
| Current Portion of Leases | 15.21M | 14.36M | 13.47M | 12.78M | 12.23M | 9.83M |
| Current Unearned Revenue | 6.66M | 108.86M | 68.71M | 135.97M | 86.27M | |
| Other Current Liabilities | 24.70M | 16.05M | 19.74M | 87.42M | 35.64M | 53.00M |
| Total Current Liabilities | 80.88M | 96.94M | 182.07M | 205.56M | 223.59M | 213.44M |
| Long-Term Leases | 131.89M | 139.76M | 147.96M | 159.91M | 168.62M | 137.82M |
| Long-Term Unearned Revenue | 33.22M | 109.89M | 202.18M | 262.30M | ||
| Other Long-Term Liabilities | 5.88M | 6.12M | 7.04M | 3.02M | 13.84M | 34.16M |
| Total Liabilities | 318.91M | 242.82M | 370.28M | 478.38M | 608.24M | 647.72M |
| Common Stock | 1.03M | 1.02M | 836.00K | 816.00K | 712.00K | 684.00K |
| Additional Paid-In Capital | 2.93B | 2.88B | 2.30B | 2.17B | 1.79B | 1.59B |
| Retained Earnings | -1.86B | -1.64B | -1.57B | -1.19B | -1.06B | -768.27M |
| Comprehensive Income & Other | -2.19M | 1.11M | 679.00K | 604.00K | -2.43M | -50.00K |
| Total Common Equity | 1.07B | 1.24B | 733.54M | 981.33M | 733.47M | 826.74M |
| Shareholders' Equity | 1.07B | 1.24B | 733.54M | 981.33M | 733.47M | 826.74M |
| Total Liabilities & Equity | 1.39B | 1.48B | 1.10B | 1.46B | 1.34B | 1.47B |
| Total Debt | 247.36M | 154.12M | 161.43M | 172.69M | 180.86M | 147.64M |
| Net Cash (Debt) | 905.57M | 1.09B | 689.32M | 1.02B | 897.28M | 818.00M |
| Net Cash Per Share | 8.77 | 11.03 | 8.37 | 13.18 | 12.82 | 12.74 |
| Filing Date Shares Outstanding | 99.93M | 99.31M | 81.11M | 78.73M | 70.70M | 67.60M |
| Total Common Shares Outstanding | 99.90M | 99.21M | 81.06M | 78.71M | 69.58M | 67.26M |
| Working Capital | 1.10B | 1.17B | 696.08M | 1.01B | 869.30M | 1.06B |
| Book Value Per Share | 10.68 | 12.48 | 9.05 | 12.47 | 10.54 | 12.29 |
| Tangible Book Value | 1.07B | 1.24B | 733.54M | 981.33M | 733.47M | 826.74M |
| Tangible Book Value Per Share | 10.68 | 12.48 | 9.05 | 12.47 | 10.54 | 12.29 |
| Machinery | 86.10M | 85.04M | 79.79M | 69.67M | 54.79M | 35.23M |
| Construction In Progress | 4.37M | 2.82M | 2.53M | 5.28M | 5.20M | 7.35M |
| Leasehold Improvements | 111.94M | 110.76M | 101.19M | 100.19M | 85.80M | 57.76M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -86.52M | -79.99M | -376.74M | -132.53M | -289.09M | -370.64M |
| Depreciation & Amortization | 22.24M | 22.29M | 21.93M | 20.01M | 14.15M | 7.45M |
| Asset Writedown & Restructuring Costs | 14.51M | 14.51M | 154.95M | |||
| Loss (Gain) From Sale of Investments | -270.02M | -274.65M | -8.67M | -11.15M | -29.61M | -17.77M |
| Loss (Gain) on Equity Investments | 25.50M | |||||
| Stock-Based Compensation | 81.52M | 94.24M | 120.66M | 98.65M | 84.32M | 43.57M |
| Other Operating Activities | 15.14M | 9.51M | 5.80M | -7.72M | -34.37M | 4.91M |
| Change in Accounts Receivable | 300.00M | -300.00M | ||||
| Change in Accounts Payable | 3.04M | 6.04M | 1.81M | -7.58M | 2.37M | 818.00K |
| Change in Unearned Revenue | -126.14M | -135.42M | -36.52M | -159.56M | -35.92M | 348.16M |
| Change in Other Net Operating Assets | -13.28M | -1.64M | -75.51M | 50.68M | -14.82M | 62.28M |
| Operating Cash Flow | -359.38M | -345.10M | -347.25M | -149.19M | 22.53M | -66.27M |
| Capital Expenditures | -13.39M | -14.95M | -8.95M | -33.73M | -48.95M | -46.81M |
| Cash Acquisitions | -78.00K | -78.00K | 620.00K | |||
| Investment in Securities | 202.93M | -106.41M | 193.95M | 105.57M | -412.38M | -247.95M |
| Investing Cash Flow | 189.46M | -121.44M | 185.01M | 71.84M | -461.34M | -294.14M |
| Long-Term Debt Repaid | -485.00K | -2.25M | -2.29M | -2.12M | ||
| Net Debt Issued (Repaid) | 93.89M | -485.00K | -2.25M | -2.29M | -2.12M | |
| Issuance of Common Stock | 14.62M | 478.05M | 8.22M | 278.70M | 114.06M | 767.08M |
| Other Financing Activities | -813.00K | -188.00K | -8.82M | |||
| Financing Cash Flow | 107.69M | 478.05M | 7.74M | 276.45M | 111.59M | 756.14M |
| Net Cash Flow | -62.23M | 11.51M | -154.50M | 199.09M | -327.22M | 395.73M |
| Free Cash Flow | -372.77M | -360.05M | -356.19M | -182.93M | -26.42M | -113.08M |
| Free Cash Flow Margin | -238.90% | -257.65% | -560.77% | -48.43% | -43.38% | -218.11% |
| Free Cash Flow Per Share | -3.61 | -3.64 | -4.33 | -2.37 | -0.38 | -1.76 |
| Levered Free Cash Flow | -241.84M | -220.31M | -156.52M | -50.36M | 138.32M | -335.34M |
| Unlevered Free Cash Flow | -241.94M | -220.31M | -156.52M | -50.36M | 138.32M | -335.34M |
| Cash Interest Paid | 2.57M | 32.00K | 160.00K | 376.00K | 567.00K | |
| Change in Working Capital | -136.38M | -131.02M | -110.22M | -116.45M | 251.63M | 111.25M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 2.72B | 2.74B | 1.97B | 2.16B | 2.69B | 5.33B |
| Enterprise Value | 1.82B | 1.81B | 1.21B | 1.32B | 1.78B | 4.54B |
| Last Close Price | 27.23 | 27.72 | 24.80 | 27.22 | 39.11 | 79.69 |
| PS Ratio | 17.44 | 19.58 | 31.08 | 5.72 | 44.18 | 102.75 |
| PB Ratio | 2.55 | 2.21 | 2.69 | 2.20 | 3.67 | 6.44 |
| P/TBV Ratio | 2.55 | 2.21 | 2.69 | 2.20 | 3.67 | 6.44 |
| P/OCF Ratio | 119.48 | |||||
| EV/Sales Ratio | 11.63 | 12.97 | 19.05 | 3.49 | 29.14 | 87.56 |
| Debt / Equity Ratio | 0.23 | 0.12 | 0.22 | 0.18 | 0.25 | 0.18 |
| Net Debt / Equity Ratio | -0.85 | -0.88 | -0.94 | -1.04 | -1.22 | -0.99 |
| Net Debt / EBITDA Ratio | 2.54 | 3.02 | 1.75 | 6.50 | 2.77 | 3.56 |
| Net Debt / FCF Ratio | 2.43 | 3.03 | 1.94 | 5.56 | 33.96 | 7.23 |
| Asset Turnover | 0.11 | 0.11 | 0.05 | 0.27 | 0.04 | 0.05 |
| Quick Ratio | 14.25 | 12.85 | 4.67 | 5.79 | 4.82 | 5.93 |
| Current Ratio | 14.57 | 13.09 | 4.82 | 5.89 | 4.89 | 5.96 |
| Return on Equity (ROE) | -8.18% | -8.11% | -43.94% | -15.46% | -37.06% | -69.13% |
| Return on Assets (ROA) | -17.01% | -18.55% | -20.26% | -7.88% | -15.02% | -15.41% |
| Return on Capital Employed (ROCE) | -29.00% | -27.70% | -45.10% | -14.10% | -30.30% | -18.80% |
| Earnings Yield | -3.08% | -2.92% | -19.09% | -6.14% | -10.74% | -6.96% |
| FCF Yield | -13.70% | -13.16% | -18.05% | -8.47% | -0.98% | -2.12% |
| Buyback Yield / Dilution | -16.29% | -20.16% | -6.69% | -10.19% | -9.01% | -37.44% |